• FDA approves Botox label expansion for adult upper limb spasticity

    1 month ago - By Healio

    The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the treatment of upper limb spasticity in adults, according to a press release.
    Botox (onabotulinumtoxinA, Allergan, an AbbVie company) is designed to treat adult upper limb spasticity, which is commonly caused by stroke, multiple sclerosis, spinal cord injury, cerebral palsy and traumatic brain injury, according to the release.
    With more than 10 years of clinical use and an established safety profile, onabotulinumtoxinA is now expanded for use in the brachialis, brachioradialis...
    Read more ...